President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...

Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...

The Food and Drug Administration’s recent approval of a second generic version of the abortion pill mifepristone has left people on both sides of the reproductive rights fight scrambling to interpret ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Marcel Botha, CEO of 10XBeta, discusses FDA’s new pilot authorization program for abbreviated new drug applications (ANDA) and what impact it will have on manufacturing and the supply chain.

With the S&P 500 ($SPX) up 22.8% over the past six months and the Nasdaq ($NDX) surging an even stronger 36.0%, there’s no ...

Merck Serono has failed to convince a US appeals court to overturn a PTAB decision invalidating two dosing regimen patents ...